{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Totnes&hansardHeading=Drugs%3A+Misuse", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberConstituency=Totnes&hansardHeading=Drugs%3A+Misuse", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Totnes&_metadata=all&hansardHeading=Drugs%3A+Misuse", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&tablingMemberConstituency=Totnes&hansardHeading=Drugs%3A+Misuse", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Totnes&hansardHeading=Drugs%3A+Misuse", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Totnes&hansardHeading=Drugs%3A+Misuse", "items" : [{"_about" : "http://data.parliament.uk/resources/722136", "AnsweringBody" : [{"_value" : "Home Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/722136/answer", "answerText" : {"_value" : "<p>We are currently developing the new Drug Strategy, working across government and with key partners. The new strategy will be published in due course.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4071", "label" : {"_value" : "Biography information for Sarah Newton"}
        }
        , "answeringMemberConstituency" : {"_value" : "Truro and Falmouth"}
        , "answeringMemberPrinted" : {"_value" : "Sarah Newton"}
        , "dateOfAnswer" : {"_value" : "2017-04-24", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2017-04-24T12:22:12.483Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "1"}
      , "answeringDeptShortName" : {"_value" : "Home Office"}
      , "answeringDeptSortName" : {"_value" : "Home Office"}
      , "date" : {"_value" : "2017-04-18", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Drugs: Misuse"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for the Home Department, when the Government's new Drug Strategy will be published.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4073", "label" : {"_value" : "Biography information for Dr Sarah Wollaston"}
      }
      , "tablingMemberConstituency" : {"_value" : "Totnes"}
      , "tablingMemberPrinted" : [{"_value" : "Dr Sarah Wollaston"}
      ], "uin" : "71008"}
    , {"_about" : "http://data.parliament.uk/resources/707685", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/707685/answer", "answerText" : {"_value" : "<p>The provision of both harm reduction and abstinence based interventions is essential to any drug treatment system. Each local authority is responsible for ensuring there is a full range of drug treatment services available in their area to meet the needs of their local population.<\/p><p> <\/p><p>During the recent Public Health England led inquiry into the rise in drug-related deaths, analysis of the treatment population did not establish a direct relationship between a policy focus on abstinence and drug-related deaths.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberConstituency" : {"_value" : "Oxford West and Abingdon"}
        , "answeringMemberPrinted" : {"_value" : "Nicola Blackwood"}
        , "dateOfAnswer" : {"_value" : "2017-03-09", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2017-03-09T09:49:53.323Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2017-03-03", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Drugs: Misuse"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, what assessment he has made of the effect of the abstinence based approach for the treatment of drug addiction on levels of deaths from drug misuse.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4073", "label" : {"_value" : "Biography information for Dr Sarah Wollaston"}
      }
      , "tablingMemberConstituency" : {"_value" : "Totnes"}
      , "tablingMemberPrinted" : [{"_value" : "Dr Sarah Wollaston"}
      ], "uin" : "66453"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}